Synchron Demonstrates First-of-its-Kind thought-controlled Use of Apple iPad

Synchron has released the first public demonstration of an individual controlling an iPad entirely by thought. The achievement was made possible through Apple’s accessibility features working in tandem with a newly developed Brain-Computer Interface Human Interface Device (BCI HID) standard.

Using Synchron’s implantable brain interface, the participant was able to move around the iPad’s home screen, launch apps, and compose text — all without the use of hands, speech, or eye-tracking.

This breakthrough comes shortly after Apple introduced a system-wide input protocol in May that, for the first time, enables its devices to accept brain signals as a native form of interaction.

The technology relies on Apple’s Switch Control accessibility tool, paired with Synchron’s Stentrode™ implant. The device sits inside blood vessels of the brain, where it records motor-related neural activity. Those signals are then transmitted wirelessly to a decoder, which communicates directly with iPadOS through the new HID protocol.

The system works as a closed loop: the iPad, iPhone, or Apple Vision Pro sends visual feedback to the decoder, which allows for real-time, precise, and natural-feeling thought-based navigation.

Synchron is the first company to test a permanently implantable BCI in clinical trials. Unlike open-brain procedures, its endovascular method uses blood vessels to place the implant, making the approach far less invasive and more suitable for widespread adoption.

This demonstration marks a major step forward for assistive technology, providing a preview of how brain-computer interfaces could eventually become part of routine digital interaction. For now, Synchron is rolling out the HID-enabled system in controlled clinical environments, with broader availability planned in the future.

The milestone is seen as an essential step toward making brain-controlled computing scalable, practical, and accessible beyond the research lab.